OptimizeRx Corp is engaged in the healthcare market in the United States... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HUTG | 8.01 | 0.55 | +7.37% |
| Leverage Shares 2X Long HUT Daily ETF (HUTG) | |||
| VVR | 2.86 | 0.02 | +0.70% |
| Invesco Senior Income Trust | |||
| SMOX | 28.98 | 0.13 | +0.44% |
| Horizon Small/Mid Cap Core Equity ETF (SMOX) | |||
| AUGZ | 46.38 | 0.06 | +0.14% |
| TrueShares Structured Outcome (August) ETF (AUGZ) | |||
| BCI | 26.12 | -0.14 | -0.53% |
| abrdn Bloomberg All Commodity Strategy K-1 Free ETF (BCI) | |||
A.I.dvisor indicates that over the last year, OPRX has been loosely correlated with DOCS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPRX jumps, then DOCS could also see price increases.
| Ticker / NAME | Correlation To OPRX | 1D Price Change % | ||
|---|---|---|---|---|
| OPRX | 100% | +4.93% | ||
| DOCS - OPRX | 42% Loosely correlated | +0.69% | ||
| CXM - OPRX | 38% Loosely correlated | -0.47% | ||
| COIN - OPRX | 37% Loosely correlated | +3.65% | ||
| RIOT - OPRX | 36% Loosely correlated | +1.82% | ||
| CERT - OPRX | 35% Loosely correlated | +4.04% | ||
More | ||||
| Ticker / NAME | Correlation To OPRX | 1D Price Change % |
|---|---|---|
| OPRX | 100% | +4.93% |
| Services to the Health Industry industry (42 stocks) | 17% Poorly correlated | -0.97% |
| Health Services industry (240 stocks) | -0% Poorly correlated | -0.00% |
a provider of unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products
Industry ServicestotheHealthIndustry
The 50-day moving average for OPRX moved above the 200-day moving average on October 07, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on OPRX as a result. In 69 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for OPRX just turned positive on October 19, 2026. Looking at past instances where OPRX's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
Following a +7.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPRX advanced for three days, in 191 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 101 of 125 cases where OPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
OPRX broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. OPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.346) is normal, around the industry mean (4.100). P/E Ratio (36.038) is within average values for comparable stocks, (13.263). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (1.463) is also within normal values, averaging (6.065).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.